Cardiovascular Journal of Africa: Vol 24 No 5 (June 2013) - page 47

CARDIOVASCULAR JOURNAL OF AFRICA • Vol 24, No 5, June 2013
AFRICA
193
the infarcted human myocardium.
Circulation
2008;
118
: 1425–1432.
21. Schaefer A, Meyer GP, Fuchs M, Klein G, Kaplan M, Wollert KC,
et al
.
Impact of intracoronary bone marrow cell transfer on diastolic function
in patients after acute myocardial infarction: results from the BOOST
trial.
Eur Heart J
2006;
27
: 929–935.
22. Schaefer A, Zwadlo C, Fuchs M, Meyer GP, Lippolt P, Wollert KC,
et
al
. Long-term effects of intracoronary bone marrow cell transfer on
diastolic function in patients after acute myocardial infarction: 5-year
results from the randomized-controlled BOOST trial – an echocardio-
graphic study.
Eur J Echocardiogr
2010;
11
: 165–171.
23. Clifford DM, Fisher SA, Brunskill SJ, Doree C, Mathur A, Clarke MJ,
et al
. Long-term effects of autologous bone marrow stem cell treatment
in acute myocardial infarction: factors that may influence outcomes.
PloS one
2012;
7
: e37373.
24. Chugh AR, Beache GM, Loughran JH, Mewton N, Elmore JB, Kajstura
J,
et al
. Administration of cardiac stem cells in patients with ischem-
ic cardiomyopathy: the SCIPIO trial: surgical aspects and interim
analysis of myocardial function and viability by magnetic resonance.
Circulation
2012;
126
: S54–64.
25. Bolli R, Chugh AR, D’Amario D, Loughran JH, Stoddard MF, Ikram
S,
et al
. Cardiac stem cells in patients with ischaemic cardiomyopathy
(SCIPIO): initial results of a randomised phase 1 trial.
Lancet
2011;
378
: 1847–1857.
26. Makkar RR, Smith RR, Cheng K, Malliaras K, Thomson LE, Berman
D,
et al
. Intracoronary cardiosphere-derived cells for heart regeneration
after myocardial infarction (CADUCEUS): a prospective, randomised
phase 1 trial.
Lancet
2012;
379
: 895–904.
27. Marban E, Cingolani E. Heart to heart: cardiospheres for myocardial
regeneration.
Heart Rhythm
2012;
9
: 1727–1731.
28. Tallini YN, Greene KS, Craven M, Spealman A, Breitbach M, Smith J,
et al.
c-kit expression identifies cardiovascular precursors in the neona-
tal heart.
Proc Nat Acad Sci USA
2009;
106
: 1808–1813.
29. Andersen DC, Andersen P, Schneider M, Jensen HB, Sheikh SP. Murine
“cardiospheres” are not a source of stem cells with cardiomyogenic
potential.
Stem Cells
2009;
27
: 1571–1581.
30. Suncion VY, Schulman IH, Hare JM. Concise review: the role of
clinical trials in deciphering mechanisms of action of cardiac cell-based
therapy.
Stem Cells Trans Med
2012;
1
: 29–35.
31. Blin G, Nury D, Stefanovic S, Neri T, Guillevic O, Brinon B,
et al
. A
purified population of multipotent cardiovascular progenitors derived
from primate pluripotent stem cells engrafts in postmyocardial infarcted
nonhuman primates.
J Clin Invest
2010;
120
: 1125–1139.
32. Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda
Y, Terzic A. Repair of acute myocardial infarction by human stemness
factors induced pluripotent stem cells.
Circulation
2009;
120
: 408–416.
33. Ieda M, Fu JD, Delgado-Olguin P, Vedantham V, Hayashi Y, Bruneau
BG,
et al
. Direct reprogramming of fibroblasts into functional cardio-
myocytes by defined factors.
Cell
2010;
142
: 375–386.
34. Gnecchi M, Zhang Z, Ni A, Dzau VJ. Paracrine mechanisms in adult
stem cell signaling and therapy.
Circ Res
2008;
103
: 1204–1219.
Cardiovascular congress diary 2013
DATE
PLACE
CONFERENCE CONTACT DETAILS TO REGISTER
JULY 2013
13–15 July
Asian Federation of Cardiology congress (AFCC)
Singapore
AUGUST 2013
25–29 August
2012 ESC, European Society of Cardiology congress
Munich, Germany
SEPTEMBER 2013
11–13 September 6th international symposium on hybrid approach to congenital heart
disease 2012
Columbus, US
OCTOBER 2013
10–12 October
Federation of Infectious Disease Society in South Africa (FIDSSA) Drakensberg, SA
13–16 October
10th international congress on coronary and artery disease from
prevention to intervention (ICCAD)
Florence, Italy
NOVEMBER 2013
16–20 November 86th American Heart Association scientific sessions (AHA)
Dallas, Texas, USA
Critical care refresher course 2013
SA
21–24 November 5th international conference of fixed combination in the treatment of
hypertension, dyslipidaemia and diabetes mellitus
Bangkok, Thailand
To advertise your conference/meeting, email details and half page PDF advert to
1...,37,38,39,40,41,42,43,44,45,46 48,49,50,51,52,53,54,55,56,57,...66
Powered by FlippingBook